Skip to main content
Clinical Trials/IRCT201702109014N143
IRCT201702109014N143
Completed
Phase 2

The incidence risk of preeclampsia in pregnant women treated with selenium supplementation versus placebo: a randomized double-blind placebo-controlled trial

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences0 sites158 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Enrollment
158
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Primigravid; first trimester.
  • Exclusion criteria: Using selenium supplementation during past year; using any medications except ferrous sulfate and folic acid; thyroid disease; diabetes; hypertension; infective diseases; diet full of selenium.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials